This is a demo store. No orders will be fulfilled.

Belimumab (anti-TNFSF13B) - Primary antibody, specific to TNFSF13B, >95%, high purity, Human IgG1, INHIBITOR of Tumor necrosis factor ligand superfamily member 13B inhibitor, INHIBITOR of Tumor necrosis factor ligand superfamily member 13B inhibitor

    Application:
  • Animal Model
  • ELISA
  • Flow Cytometry
  • Functional Assay
  • Host species: Human
  • Reactive species: Human,Mouse
  • Isotype: Human IgG1
  • Conjugation: Unconjugated
In stock
Item Number
Ab170933
Grouped product items
SKU Size
Availability
Price Qty
Ab170933-100μg
100μg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$11.90
Ab170933-1mg
1mg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$57.90
Ab170933-5mg
5mg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$117.90
Ab170933-10mg
10mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$177.90

Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated

Basic Description

Product Name Belimumab (anti-TNFSF13B) - Primary antibody, specific to TNFSF13B, >95%, high purity, Human IgG1, INHIBITOR of Tumor necrosis factor ligand superfamily member 13B inhibitor
Synonyms ApoL related ligand TALL 1 antibody | B cell Activating Factor antibody | B lymphocyte stimulator antibody | B-cell-activating factor antibody | BAFF antibody | BLyS antibody | CD 257 antibody | CD257 antibody | CD257 antigen antibody | Delta BAFF antibod
Specifications & Purity Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA
Host species Human
Specificity TNFSF13B
Conjugation Unconjugated
Grade Animal Free, Azide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated
Action Type INHIBITOR
Mechanism of action INHIBITOR of Tumor necrosis factor ligand superfamily member 13B inhibitor
Product Description

Belimumab (anti-TNFSF13B) is a human IgG1λ monoclonal antibody that inhibits B-cell activating factor (BAFF). Belimumab (anti-TNFSF13B) can be used for systemic lupus erythematosus (SLE) research.
Purity
>95% (SDS-PAGE&SEC)
Endotoxin Level
< 1.0EU/mg

Product Properties

Isotype Human IgG1
Light Chain Type lambdaC2
SDS-PAGE 28.2 kDa (Light Chain) & 52.1 kDa (Heavy Chain), under reducing conditions; 175.9 kDa, under non-reducing conditions.
Purification Method Protein A purified
Purity >95%
Shape Liquid
Concentration See COA
Storage Temp Store at -80°C,Avoid repeated freezing and thawing
Shipped In Ice chest + Ice pads
Stability And Storage Store at -80℃ for 24 months. Upon receipt, it is recommended to aliquot. Avoid freeze/thaw cycle.
CAS 356547-88-1

Associated Targets(Human)

TNFSF13B Tclin Tumor necrosis factor ligand superfamily member 13B (0 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)

Mechanisms of Action

Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References

Images

Belimumab (anti-TNFSF13B) (Ab170933) - SEC
The purity of Belimumab (anti-TNFSF13B) (Ab170933) is more than 95% verified by HPLC.

Certificates(CoA,COO,BSE/TSE and Analysis Chart)

C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

3 results found

Lot Number Certificate Type Date Item
ZJ24F0911502 Certificate of Analysis Sep 30, 2024 Ab170933
ZJ23F1001437 Certificate of Analysis Oct 26, 2023 Ab170933
ZJ23F1001436 Certificate of Analysis Oct 26, 2023 Ab170933

Solution Calculators

Reviews

Customer Reviews

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.